Anhaltendes Ansprechen auf IL-23p19-Inhibitor bei Colitis ulcerosa

被引：0
|
作者：
Monika Walter
机构：
[1] Freie Medizinjournalistin,
来源：
Gastro-News | 2024年 / 11卷 / 2期
关键词：
D O I：
10.1007/s15036-024-3705-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：59 / 59
相关论文
共 50 条
  • [41] Tildrakizumab: monoclonal antibody against IL-23p19 for moderate to severe psoriasis
    Paton, D. M.
    DRUGS OF TODAY, 2018, 54 (07) : 433 - 444
  • [42] IMMUNE CHECKPOINT INHIBITOR-INDUCED COLITIS IS MEDIATED BY IL23 RESPONSIVE CD90+CYTOTOXIC LYMPHOCYTES
    Lo, Jonathan
    Cozzetto, Domenico
    Sieh, Jillian Yong Xin
    Madgwick, Matthew
    Kudo, Hiromi
    Alexander, James
    Miguens-Blanco, Jesus
    Korcsmaros, Tamas
    Goldin, Robert
    Marchesi, Julian
    Lord, Graham
    Powell, Nick
    GUT, 2021, 70 : A77 - A77
  • [43] Immune checkpoint inhibitor-induced colitis is mediated by IL23 responsive CD90+cytotoxic lymphocytes
    Lo, Jonathan Wai Pang
    Cozzetto, Domenico
    Sieh, Jillian Yong Xin
    Alexander, James L.
    Blanco, Jesus Miguens
    Madgwick, Matthew
    Korcsmaros, Tamas
    Kudo, Hiromi
    Goldin, Robert
    Marchesi, Julian
    Lord, Graham M.
    Powell, Nick
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 81 - 81
  • [44] Increased expression of IL-23p19 on peripheral-blood mononuclear cells and serum IL-23 in patients with primary cirrhosis biliary
    Qian, Cheng
    Deng, An-mei
    Zhong, Ren-qian
    FASEB JOURNAL, 2008, 22
  • [45] Expression of sheep interleukin 23 (IL23A, alpha subunit p19) in two distinct gastrointestinal diseases
    Gossner, Anton G.
    Venturina, Virginia M.
    Peers, Anna
    Watkins, Craig A.
    Hopkins, John
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2012, 150 (1-2) : 118 - 122
  • [46] IL-23 Dependent and Independent Stages of Experimental Arthritis: No Clinical Effect of Therapeutic IL-23p19 Inhibition in Collagen-induced Arthritis
    Cornelissen, Ferry
    Asmawidjaja, Patrick S.
    Mus, Adriana M. C.
    Corneth, Odilia
    Kikly, Kristine
    Lubberts, Erik
    PLOS ONE, 2013, 8 (02):
  • [47] Enhanced interferon regulatory factor 3 binding to the IL-23p19 promoter correlates with enhanced IL-23 expression in Systemic Lupus Erythematosus
    Smith, S.
    Gabhann, J. Ni
    Stacey, K.
    Espinosa, A.
    Wahren-Herlenius, M.
    Kearns, G.
    O'Neill, L.
    Ball, E.
    Johnston, J. A.
    Bell, A.
    Grazia-Totaro, M.
    Sica, A.
    Jefferies, C. A.
    IMMUNOLOGY, 2012, 137 : 45 - 45
  • [48] IBI112, a selective anti-IL23p19 monoclonal antibody, displays high efficacy in IL-23-induced psoriasiform dermatitis
    Li, Li
    Wu, Zhihai
    Wu, Min
    Qiu, Xuan
    Wu, Yue
    Kuang, Zhihui
    Wang, Li
    Sun, Ta
    Liu, Yang
    Yi, Shuai
    Jing, Hua
    Zhou, Shuaixiang
    Chen, Bingliang
    Wu, Dongdong
    Wu, Weiwei
    Liu, Junjian
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 89
  • [49] Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia
    Li, Yonghai
    Chu, Niansheng
    hu, Aia Hu
    Gran, Bruno
    Rostami, Abdolmohamad
    Zhang, Guang-Xian
    BRAIN, 2007, 130 : 490 - 501
  • [50] Anti-IL-23p19 (MK-3222): effects on the hallmarks of inflammation in psoriasis
    Bangert, C.
    Laimer, D.
    Riedl, E.
    Greisenegger, E.
    Horowitz, A.
    Xu, D.
    Liu, R.
    Morrison, M.
    Stingl, G.
    Kopp, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S51 - S51
12345